Cargando…
Increased circulating bioactive C-type natriuretic peptide is associated with reduced heart rate variability in patients with chronic kidney disease
BACKGROUND: C-type natriuretic peptide (CNP) is a member of the natriuretic peptide family and have been implicated to be involved in maintaining vascular homeostasis and acting as a cardiac chronotropic agent in experimental studies. However, clinical evidence of its participation in cardiovascular...
Autores principales: | Wang, Lulu, Liu, Wenjin, Yu, Yanting, Jiang, Lei, Yang, Junwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839007/ https://www.ncbi.nlm.nih.gov/pubmed/29506482 http://dx.doi.org/10.1186/s12882-018-0843-3 |
Ejemplares similares
-
Elevated circulating growth differentiation factor 15 is related to decreased heart rate variability in chronic kidney disease patients
por: Wang, Lulu, et al.
Publicado: (2021) -
High N-Terminal Pro-B-Type Natriuretic Peptide Levels Are Associated with Reduced Heart Rate Variability in Acute Myocardial Infarction
por: Lorgis, Luc, et al.
Publicado: (2012) -
Natriuretic Peptides in Chronic Heart Failure
por: Brunner-La Rocca, Hans-Peter, et al.
Publicado: (2019) -
Enhancing natriuretic peptide bioactivity prevents bleomycin-induced pulmonary fibrosis
por: Baliga, Reshma S, et al.
Publicado: (2011) -
Acute effects of insulin on circulating natriuretic peptide levels in humans
por: Bachmann, Katherine N., et al.
Publicado: (2018)